Letter to the Editor: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
- PMID: 33016343
- DOI: 10.1002/hep.31590
Letter to the Editor: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
Comment in
-
Reply.Hepatology. 2021 Mar;73(3):1241. doi: 10.1002/hep.31587. Epub 2021 Feb 26. Hepatology. 2021. PMID: 33020938 No abstract available.
Comment on
-
Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection.Hepatology. 2021 Feb;73(2):661-673. doi: 10.1002/hep.31289. Epub 2020 Nov 2. Hepatology. 2021. PMID: 32324905
References
-
- Choi J, Jo C, Lim YS. Tenofovir vs. entecavir on recurrence of hepatitis B virus–related hepatocellular carcinoma after surgical resection. Hepatology 2020 Apr 23. https://doi.org/10.1002/hep.31289 . [Epub ahead of print] - DOI
-
- Saitta C, Pollicino T, Raimondo G. Obesity and liver cancer. Ann Hepatol 2019;18:810‐815.
-
- Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg 2019;269:924‐931.
-
- Li X, Liu L, Hu Y. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta‐analysis. Biosci Rep 2020;40:BSR20200232.
-
- Zaleska M, Mozenska O, Bil J. Statins use and cancer: an update. Future Oncol 2018;14:1497‐1509.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
